Welcome to our dedicated page for Broadridge Finl Solutions SEC filings (Ticker: BR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Broadridge Financial Solutions, Inc. (NYSE: BR), a global Fintech and technology company serving the financial services industry. Broadridge’s filings offer detailed insight into its technology and operations platforms that power investing, governance, and communications, support post-trade processing and asset servicing, and underpin the daily average trading of more than $15 trillion in securities globally.
Through Broadridge’s annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review discussions of its business model, segment performance, risk factors, and financial condition. The company’s definitive proxy statement on Schedule 14A describes corporate governance practices, Board composition, executive compensation, and matters submitted to stockholder vote, including the election of directors, advisory votes on executive pay, and ratification of independent auditors.
Broadridge also files frequent current reports on Form 8-K that disclose material events such as dividend declarations, earnings releases, financing arrangements like term credit agreements, investor presentations, and results of stockholder meetings. These filings can include information on the company’s capital allocation approach, including recurring cash dividends, as well as updates on its growth strategy and operational priorities.
In addition, investors can monitor Forms 3, 4, and 5 for information on insider share ownership and changes in holdings by directors and officers, and Schedule 13 filings for significant beneficial ownership by large shareholders, where applicable. Together, these documents provide a regulatory record of Broadridge’s activities as a public company listed on the New York Stock Exchange.
On Stock Titan, Broadridge’s SEC filings are supplemented with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand major themes in 10-K and 10-Q reports, the implications of 8-K disclosures, and notable aspects of proxy materials. Real-time updates from EDGAR, combined with simplified explanations, support investors, analysts, and researchers who want to follow BR’s governance, risk disclosures, capital structure, and corporate actions in a structured and accessible way.
BR reported a planned sale of restricted stock under Rule 144. A holder intends to sell 3984 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 900384. The shares were acquired on 04/01/2025 through restricted stock vesting under a registered plan from the issuer. The notice lists 116727559 shares of the issuer’s common stock outstanding, providing context for the relative size of this planned sale.
Broadridge Financial Solutions (BR) reported an insider stock sale by a company officer who serves as President. On 11/18/2025, the officer sold 3,984 shares of Broadridge common stock in an open market transaction coded "S" at a price of $226 per share. After this transaction, the officer continued to beneficially own 44,828.521 shares of Broadridge common stock, held in direct ownership. This filing reflects a routine Form 4 disclosure of insider trading activity by a single reporting person.
Broadridge Financial Solutions (BR) director reported receiving 459 shares of common stock on 11/13/2025 as a Deferred Stock Unit grant under Broadridge's 2018 Omnibus Award Plan.
The filing also reports a stock option grant for 1,758 shares at an exercise price of $225.61, vesting immediately and expiring on 11/13/2035. After the stock grant, the director beneficially owned 8,343 common shares held directly. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock when the director separates from service.
Broadridge Financial Solutions (BR)11/13/2025, the director received 459 shares of common stock at a price of $0.0000, increasing the director’s directly held stake to 8,987 shares. The director was also granted a stock option for 1,758 shares with an exercise price of $225.61, exercisable from 11/13/2025 and expiring on 11/13/2035. The stock grant reflects Deferred Stock Units issued under Broadridge’s 2018 Omnibus Award Plan, which vest immediately and will be settled in shares when the director leaves board service, while the stock options also vest immediately upon grant.
Broadridge Financial Solutions, Inc. (BR) reported a routine director equity award on a Form 4. On 11/13/2025, a director received 831 Deferred Stock Units of Broadridge common stock at $0.0000 per unit, increasing the director’s directly held common stock to 4,543 shares after the transaction. The director was also granted a stock option for 3,182 shares with an exercise price of $225.61 per share, vesting immediately and expiring on 11/13/2035. The Deferred Stock Units vest in full upon grant and will be settled in shares when the director separates from service with Broadridge.
Broadridge Financial Solutions, Inc. (BR) reported equity awards for one of its directors. On 11/13/2025, the director received 459 Deferred Stock Units of Broadridge common stock at a stated price of $0.0000, increasing the director’s directly held common stock to 31,780.102 shares. These Deferred Stock Units vest in full upon grant and will be settled in shares of common stock when the director leaves service.
On the same date, the director was also granted a stock option covering 1,758 shares of Broadridge common stock with an exercise price of $225.61 per share. The option vests immediately and is exercisable from 11/13/2025 until its expiration on 11/13/2035. Both awards are made under Broadridge’s 2018 Omnibus Award Plan and reflect standard equity-based director compensation.
Broadridge Financial Solutions (BR) reported an equity award to one of its directors. On 11/13/2025, the director received 459 Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan, representing the same number of shares of common stock. These units vest in full upon grant and will be settled in shares of Broadridge common stock when the director separates from service. The filing also shows a grant of 1,758 stock options with an exercise price of $225.61 per share, which vest immediately and expire on 11/13/2035. Following the stock unit grant, the director directly owns 2,649 shares of Broadridge common stock, in addition to the stock options.
Broadridge Financial Solutions (BR) filed a Form 4 for a company director reporting new equity awards granted on 11/13/2025. The director received 459 shares of common stock in the form of Deferred Stock Units at a price of $0.0000, increasing the director’s directly held common stock to 16,516 shares. The Deferred Stock Units vest in full upon grant and will be settled in Broadridge common stock when the director separates from service.
The filing also discloses a new stock option grant for 1,758 shares with an exercise price of $225.61 per share. These options vest immediately upon grant and are exercisable until their expiration on 11/13/2035. Both the common stock and the options are reported as directly owned by the director.
Broadridge Financial Solutions director equity awards reported
A director of Broadridge Financial Solutions, Inc. (BR) reported receiving 459 shares of common stock on 11/13/2025 at a stated price of $0.0000. The filing explains this reflects a grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan, which vest in full upon grant and will be settled in common shares when the director leaves board service.
The director also received a stock option covering 1,758 shares of Broadridge common stock at an exercise price of $225.61, which vests immediately and expires on 11/13/2035. Following these transactions, the director reports 20,977 shares held directly and additional indirect holdings through BOMAR II LLC and two revocable trusts.
Broadridge Financial Solutions reported the results of its 2025 Annual Meeting of Stockholders, where all management proposals were approved.
Stockholders elected 8 directors to one-year terms. Individual support levels were disclosed, including Timothy C. Gokey with 95,437,365 votes For and Brett A. Keller with 94,268,327 votes For.
The advisory vote to approve executive compensation passed with 87,706,467 votes For, 8,019,679 Against, and 186,912 Abstentions. Stockholders also ratified Deloitte & Touche LLP as the independent registered public accountants for the fiscal year ending June 30, 2026, with 101,741,761 votes For, 1,888,802 Against, and 65,375 Abstentions.
FAQ
What is the current stock price of Broadridge Finl Solutions (BR)?
What is the market cap of Broadridge Finl Solutions (BR)?
